A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 4,080,381 shares of ABBV stock, worth $790 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
4,080,381
Previous 4,367,381 6.57%
Holding current value
$790 Million
Previous $795 Million 12.0%
% of portfolio
0.52%
Previous 0.55%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $44.4 Million - $51.9 Million
-287,000 Reduced 6.57%
4,080,381 $700 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $9.76 Million - $11.1 Million
-61,058 Reduced 1.38%
4,367,381 $795 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $2.13 Million - $2.39 Million
-15,453 Reduced 0.35%
4,428,439 $686 Million
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $6.41 Million - $7.42 Million
-47,992 Reduced 1.07%
4,443,892 $662 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $87.8 Million - $109 Million
-662,544 Reduced 12.85%
4,491,884 $605 Million
Q1 2023

Apr 27, 2023

SELL
$144.61 - $166.54 $13.3 Million - $15.3 Million
-91,711 Reduced 1.75%
5,154,428 $821 Million
Q4 2022

Jan 30, 2023

SELL
$138.31 - $165.87 $234,297 - $280,983
-1,694 Reduced 0.03%
5,246,139 $848 Million
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $4.9 Million - $5.62 Million
-36,478 Reduced 0.69%
5,247,833 $704 Million
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $58.5 Million - $74.4 Million
-425,086 Reduced 7.45%
5,284,311 $809 Million
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $65 Million - $80.7 Million
-492,851 Reduced 7.95%
5,709,397 $926 Million
Q4 2021

Feb 02, 2022

SELL
$107.43 - $135.93 $102 Million - $129 Million
-952,367 Reduced 13.31%
6,202,248 $840 Million
Q3 2021

Oct 25, 2021

BUY
$106.4 - $120.78 $2.12 Million - $2.41 Million
19,933 Added 0.28%
7,154,615 $772 Million
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $55.9 Million - $62.3 Million
-531,511 Reduced 6.93%
7,134,682 $804 Million
Q1 2021

Apr 30, 2021

SELL
$102.3 - $112.62 $5.86 Million - $6.45 Million
-57,246 Reduced 0.74%
7,666,193 $830 Million
Q4 2020

Feb 05, 2021

SELL
$80.49 - $108.67 $52.3 Million - $70.6 Million
-649,937 Reduced 7.76%
7,723,439 $828 Million
Q3 2020

Oct 30, 2020

BUY
$85.91 - $100.83 $15.4 Million - $18.1 Million
179,105 Added 2.19%
8,373,376 $733 Million
Q2 2020

Jul 27, 2020

BUY
$73.37 - $98.18 $120 Million - $160 Million
1,630,022 Added 24.83%
8,194,271 $795 Million
Q1 2020

Apr 27, 2020

BUY
$64.5 - $97.79 $43 Million - $65.2 Million
666,883 Added 11.31%
6,564,249 $493 Million
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $5.73 Million - $7.16 Million
79,374 Added 1.36%
5,897,366 $515 Million
Q3 2019

Oct 31, 2019

BUY
$62.98 - $75.72 $3.06 Million - $3.68 Million
48,571 Added 0.84%
5,817,992 $441 Million
Q2 2019

Jul 29, 2019

SELL
$65.7 - $83.98 $12.5 Million - $16 Million
-190,021 Reduced 3.19%
5,769,421 $420 Million
Q1 2019

May 08, 2019

BUY
$77.14 - $90.79 $13.1 Million - $15.4 Million
170,031 Added 2.94%
5,959,442 $480 Million
Q4 2018

Feb 06, 2019

BUY
$77.85 - $96.01 $75 Million - $92.5 Million
963,633 Added 19.97%
5,789,411 $528 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $7.05 Million - $7.84 Million
79,330 Added 1.67%
4,825,778 $456 Million
Q2 2018

Aug 01, 2018

SELL
$89.78 - $106.23 $18.7 Million - $22.1 Million
-208,061 Reduced 4.2%
4,746,448 $440 Million
Q1 2018

May 01, 2018

BUY
$92.01 - $123.21 $25.9 Million - $34.7 Million
281,453 Added 6.02%
4,954,509 $469 Million
Q4 2017

Feb 06, 2018

BUY
$89.56 - $98.21 $15 Million - $16.4 Million
167,382 Added 3.71%
4,673,056 $452 Million
Q3 2017

Nov 07, 2017

SELL
$69.85 - $89.22 $4.53 Million - $5.79 Million
-64,892 Reduced 1.42%
4,505,674 $400 Million
Q2 2017

Aug 07, 2017

BUY
N/A
4,570,566
4,570,566 $331 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.